Table 2.
AIT (N = 1212) |
No-AIT (N = 377) |
Total (N = 1589) |
|
---|---|---|---|
Patients with polysensitization (n, %) | |||
Children (N = 625) | |||
N available | 476 | 135 | 611 |
Missing | 13 | 1 | 14 |
n (%) | 242 (50.8 %) | 73 (54.1 %) | 315 (51.6 %) |
Adults (N = 938) | |||
N available | 686 | 222 | 908 |
Missing | 23 | 7 | 30 |
n (%) | 425 (62.0 %) | 111 (50.0 %) | 536 (59.0 %) |
Total (n = 1589)a | |||
N available | 1170 | 366 | 1536 |
Missinga | 42 | 11 | 53 |
n (%) | 673 (57.5 %) | 190 (51.9 %) | 863 (56.2 %) |
Patients with asthma (n, %) | |||
Children (N = 625) | |||
N available | 489 | 136 | 625 |
Missing | 0 | 0 | 0 |
n (%) | 231 (47.2 %) | 48 (35.3 %) | 279 (44.6 %) |
Adults (N = 938) | |||
N available | 709 | 229 | 938 |
Missing | 0 | 0 | 0 |
n (%) | 274 (38.6 %) | 54 (23.6 %) | 328 (35.0 %) |
Total (N = 1589)a | |||
N available | 1212 | 377 | 1589 |
Missing | 0 | 0 | 0 |
n (%) | 507 (41.8 %) | 106 (28.1 %) | 613 (38.6 %) |
Patients with conjunctivitis (n, %) | |||
Children (N = 625) | |||
N available | 477 | 132 | 609 |
Missing | 12 | 4 | 16 |
n (%) | 259 (54.3 %) | 50 (37.9 %) | 309 (50.7 %) |
Adults (N = 625) | |||
N available | 687 | 225 | 912 |
Missing | 22 | 4 | 26 |
n (%) | 398 (57.9 %) | 108 (48.0 %) | 506 (55.5 %) |
Total (N = 1589)a | |||
N available | 1176 | 369 | 1545 |
Missing | 36 | 8 | 44 |
n (%) | 664 (56.5 %) | 167 (45.3 %) | 831 (53.8 %) |
aThe total population corresponding to the analysis population (N = 1589) that included patients with missing age (N = 26)